# Clinical trials recruiting in Latvia: 78 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 78 trials recruiting or not yet recruiting with a site in Latvia, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Latvia: 78 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/latvia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 78
- Recruiting or not yet: 78
- Read on: November 19, 2026

## Trials

The 25 newest of 78, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| October 15, 2026 | NCT07876232 | Comparison of Surgical Techniques for Anterior Shoulder Instability | Riga Stradins University | Not applicable | Recruiting | Surgeons, Shoulder Instability, Bankart Lesions, Bankart Repair, Dynamic Stability | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876232) |
| September 29, 2026 | NCT07845487 | A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845487) |
| September 11, 2026 | NCT07814976 | Hyoscine Butylbromide During Transcystic Papillary Balloon Dilation for Choledocholithiasis | Riga East Clinical University Hospital | Not applicable | Recruiting | Choledocholithiasis, Common Bile Duct Stones | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814976) |
| July 21, 2026 | NCT07716306 | Remotely Supervised Exercise During Chemotherapy in Women With Breast Cancer | Riga Stradins University | Not applicable | Not yet recruiting | Breast Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07716306) |
| June 16, 2026 | NCT07651826 | Immiseal™ Dural Sealant Post-Market Registry Study | Medprin Regenerative Medical Technologies Co., Ltd. | Observational | Recruiting | Dural Defect, Cerebrospinal Fluid Leak, Neurosurgical Procedures | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07651826) |
| May 29, 2026 | NCT07614776 | A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular... | Amgen | Phase 3 | Recruiting | Neovascular Age-related Macular Degeneration, nAMD | 304 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614776) |
| May 19, 2026 | NCT07596849 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease. | argenx | Phase 3 | Recruiting | Graves Disease | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07596849) |
| April 8, 2026 | NCT07517120 | Home-Based Stroke Rehabilitation Using Enriched Environments (PEER-HOMEcare) | Norwegian School of Sport Sciences | Not applicable | Not yet recruiting | Stroke | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07517120) |
| April 2, 2026 | NCT07507500 | Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Phase 4 | Recruiting | Myocardial Infarction (MI) | 8,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07507500) |
| March 24, 2026 | NCT07491809 | Adhesive Cementation Materials and Techniques in Aesthetic Dentistry | Riga Stradins University | Not applicable | Recruiting | Dental Veneers, Resin Cements, Composite Restoration, Orofacial Esthetic Scale | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07491809) |
| March 19, 2026 | NCT07483827 | A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy | eleva GmbH | Phase 1 | Recruiting | C3 Glomerulopathy (C3G), Healthy Adult Participants | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07483827) |
| March 16, 2026 | NCT07472517 | DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and... | Boehringer Ingelheim | Phase 3 | Recruiting | Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC) | 670 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472517) |
| February 27, 2026 | NCT07440225 | A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) | EyeBiotech Ltd. | Phase 2/3 | Recruiting | Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration | 960 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07440225) |
| February 27, 2026 | NCT07439458 | Tumour Cell Response to Acute Aerobic Exercise in Breast Cancer Survivors: Modulatory Effects of Exercise Type and Intensity | Riga Stradins University | Not applicable | Recruiting | Acute Exercise, Breast Cancer Cell Lines, Breast Cancer Survivors, Healthy Women, Myokine Response | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07439458) |
| February 19, 2026 | NCT07419802 | OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study | Pauls Stradins Clinical University Hospital | Observational | Recruiting | Sepsis, Septic Shock, Blood Purification, Hemoadsorption | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07419802) |
| February 17, 2026 | NCT07415044 | LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company | Phase 2 | Recruiting | Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe | 1,431 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07415044) |
| February 6, 2026 | NCT07393009 | BIO\|STREAM.CSP Study | Biotronik SE & Co. KG | Observational | Recruiting | Cardiac Pacing, Cardiac Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07393009) |
| January 22, 2026 | NCT07360834 | Study Aiming to Test Whether Non-invasive Liquid Biopsies Can Safely Reduce Invasive Surveillance Methods in Lynch Syndrome | UNICANCER | Not applicable | Not yet recruiting | Lynch Syndrome | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07360834) |
| January 6, 2026 | NCT07318597 | Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH) | Regeneron Pharmaceuticals | Phase 2 | Recruiting | Pulmonary Arterial Hypertension (PAH) | 99 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07318597) |
| December 24, 2025 | NCT07301736 | Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma | Chiesi Farmaceutici S.p.A. | Phase 2 | Recruiting | Asthma | 780 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07301736) |
| December 16, 2025 | NCT07286058 | Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis | Takeda | Phase 3 | Recruiting | Psoriatic Arthritis | 1,182 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07286058) |
| December 16, 2025 | NCT07285655 | A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD | Liquidia Technologies, Inc. | Phase 3 | Recruiting | Pulmonary Hypertension Due to Lung Disease (Disorder) | 344 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07285655) |
| December 11, 2025 | NCT07276724 | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1) | Generate Biomedicines | Phase 3 | Recruiting | Severe Asthma | 786 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07276724) |
| December 9, 2025 | NCT07272031 | Office Massage Effects on HRV and Stress | Riga Stradins University | Not applicable | Recruiting | Occupational Health, Autonomic Nervous System (ANS) Functioning and Mood State, Stress | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07272031) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Pauls Stradins Clinical University Hospital | Riga | 18 |
| Rigas Austrumu kliniska universitates slimnica SIA | Riga | 4 |
| Daugavpils regionala slimnica SIA | Daugavpils | 3 |
| Riga East Clinical University Hospital | Riga | 3 |
| Liepaja Regional Hospital | Liepāja | 2 |
| Institute of Clinical and Preventive Medicine, University of Latvia | Riga | 2 |
| Pauls Stradins Clinical University hospital | Riga | 2 |
| Pauls Stradins Clinical Univeristy Hospital | Riga | 2 |
| Daugavpils Regional Hospital | Daugavpils | 2 |
| Riga Stradins University | Riga | 2 |
| VCA Dubultu Medical center | Jūrmala | 2 |
| Mediciniskas pecdiploma izglitibas instituts SIA | Riga | 2 |
| Riga East University Hospital | Riga | 2 |
| Zemgale Diabetes Centre | Jelgava | 1 |
| Lijas Moras Medical Practice Ltd | Ogre | 1 |
| Professor Skride's Heart Clinic, LLC. | Riga | 1 |
| Sigulda Hospital | Sigulda | 1 |
| Gita Rancane's private cardiologist practice, LLC. | Ventspils | 1 |
| VCA Polyclinic DUBULTI\_Site n. 428006 | Jūrmala | 1 |
| Riga 1st Hospital\_Site n. 428003 | Riga | 1 |
| Paula Stradiņa Klīniskā Universitātes Slimnīca\_Site n. 428001 | Riga | 1 |
| Consilium Medicum\_Site n. 428002 | Riga | 1 |
| SIA Rigas Austrumu Kliniska Universitates Slimnica - Gailezers\_Site n. 428005 | Riga | 1 |
| Pauls Stradiņš Clinical University Hospital, Department of Anesthesiology and Reanimatology | Riga | 1 |
| Pauls Stradins Clinical Univeristy Hospital-Urological department | Riga | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 8 |
| Phase 2/3 | 3 |
| Phase 3 | 28 |
| Phase 4 | 2 |
| Not applicable | 18 |
| Observational | 17 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Coronary Artery Disease | 6 |
| Pulmonary Arterial Hypertension | 4 |
| Stomach Neoplasms | 4 |
| Hypertension, Pulmonary | 3 |
| Gastritis, Atrophic | 3 |
| Crohn Disease | 3 |
| Cardiovascular Diseases | 2 |
| Lung Diseases, Interstitial | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Asthma | 2 |
| Myocardial Infarction | 2 |
| Acute Coronary Syndrome | 2 |
| Ischemic Stroke | 2 |
| Colitis, Ulcerative | 2 |
| Inflammatory Bowel Diseases | 2 |
| Macular Degeneration | 2 |
| Wet Macular Degeneration | 2 |
| Depressive Disorder, Major | 2 |
| Depression | 2 |
| Venous Thromboembolism | 2 |
| Lung Neoplasms | 2 |
| Heart Failure | 2 |
| Graves Disease | 2 |
| Breast Neoplasms | 2 |
| Bronchiectasis | 2 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Riga Stradins University | 7 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 4 |
| Pauls Stradins Clinical University Hospital | 4 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 3 |
| University of Latvia | 3 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 2 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 2 |
| [Neurocrine Biosciences](https://specstream.ai/data/clinical-trials/company/neurocrine-biosciences) | 2 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 2 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| [Biotronik SE & Co. KG](https://specstream.ai/data/clinical-trials/company/biotronik-se-and-co-kg) | 2 |
| AllRock Bio, Inc. | 1 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 1 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 1 |
| [Chiesi Farmaceutici S.p.A.](https://specstream.ai/data/clinical-trials/company/chiesi-farmaceutici-s-p-a) | 1 |
| Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 1 |
| Corxel Pharmaceuticals | 1 |
| Urovant Sciences GmbH | 1 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 1 |
| Western Sydney Local Health District | 1 |
| Liquidia Technologies, Inc. | 1 |
| Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) | 1 |
| 4D Molecular Therapeutics | 1 |
| EyeBiotech Ltd. | 1 |
| Dianthus Therapeutics | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Immigration law firms in the United States](https://specstream.ai/data/businesses/immigration-law-firms/united-states)
- [Fabric wholesalers in the United States](https://specstream.ai/data/businesses/fabric-wholesalers/united-states)
- [Commercial printers in the United States](https://specstream.ai/data/businesses/commercial-printers/united-states)
- [B2B science and technology companies in the United States](https://specstream.ai/data/businesses/b2b-science-and-technology-companies/united-states)
- [Water heater installers in the United States](https://specstream.ai/data/businesses/water-heater-installers/united-states)
- [Skylight installation companies in the United States](https://specstream.ai/data/businesses/skylight-installation-companies/united-states)
